ARTICLE SUMMARY:
SI-Bone’s decision to sign onto the YODA Project indicates its confidence in the studies backing its iFuse implant. As a small company in a field where clinical evidence has been in short supply, and its decision to share its clinical trial data could be viewed as an isolated case, but data-sharing is an increasingly important issue in life sciences.
The Yale Open Data Access (YODA) Project broke ground in the medical device world in 2013 when it helped sort out the controversy over Medtronic plc’s popular InFuse recombinant human bone morphogenetic protein-2 (rhBMP-2), a bone growth factor used in spinal fusion surgery.
